Kim T Mueser1, Lindy Fox. 1. Department of Psychiatry, Dartmouth Medical School, New Hampshire-Dartmouth Psychiatric Research Center, Concord 03301, USA. kim.t.mueser@dartmouth.edu
Abstract
OBJECTIVE: To provide a rationale for working with families of clients with psychiatric and substance use disorder, and to describe a new program, family intervention for dual disorders (FIDD). METHOD: We developed and manualized the FIDD program, which includes both single-family and multiple-family group formats. We trained several clinicians at a local mental health center in the model and conducted a small pilot study. RESULTS: Clinicians were able to implement the program, and to successfully engage families in treatment. Most clients demonstrated significant improvements in substance abuse over one to two years of treatment. CONCLUSIONS: The FIDD program is feasible and appears to promote collaboration between families and professionals, thereby improving the course of dual disorders. Controlled research is underway to evaluate the effects of the FIDD program on client and family outcomes.
OBJECTIVE: To provide a rationale for working with families of clients with psychiatric and substance use disorder, and to describe a new program, family intervention for dual disorders (FIDD). METHOD: We developed and manualized the FIDD program, which includes both single-family and multiple-family group formats. We trained several clinicians at a local mental health center in the model and conducted a small pilot study. RESULTS: Clinicians were able to implement the program, and to successfully engage families in treatment. Most clients demonstrated significant improvements in substance abuse over one to two years of treatment. CONCLUSIONS: The FIDD program is feasible and appears to promote collaboration between families and professionals, thereby improving the course of dual disorders. Controlled research is underway to evaluate the effects of the FIDD program on client and family outcomes.
Authors: N R Schooler; S J Keith; J B Severe; S M Matthews; A S Bellack; I D Glick; W A Hargreaves; J M Kane; P T Ninan; A Frances; M Jacobs; J A Lieberman; R Mance; G M Simpson; M G Woerner Journal: Arch Gen Psychiatry Date: 1997-05
Authors: Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman Journal: Schizophr Bull Date: 2012-01-26 Impact factor: 9.306
Authors: Kim T Mueser; Jennifer D Gottlieb; Corrine Cather; Shirley M Glynn; Roberto Zarate; Lindy F Smith; Robin E Clark; Rosemarie Wolfe Journal: Psychosis Date: 2012-01-01
Authors: William C Torrey; Robert E Drake; Michael Cohen; Lindy B Fox; David Lynde; Paul Gorman; Philip Wyzik Journal: Community Ment Health J Date: 2002-12
Authors: Kim T Mueser; Shirley M Glynn; Corinne Cather; Roberto Zarate; Lindy Fox; James Feldman; Rosemarie Wolfe; Robin E Clark Journal: Addict Behav Date: 2009-04-01 Impact factor: 3.913
Authors: Joanna L Henderson; E B Brownlie; Shelley McMain; Gloria Chaim; David A Wolfe; Brian Rush; Tali Boritz; Joseph H Beitchman Journal: Early Interv Psychiatry Date: 2017-07-26 Impact factor: 2.732